The technology features genetically modified HCT116 colon cancer cells, where a triple-Flag tag has been precisely inserted into the N-terminus of the endogenous p73 gene using AAV-mediated gene targeting. This modification, performed in p53-wildtype cells, permits specific detection and biochemical analysis of the TAp73 isoform in various cellular contexts. The cell lines provide robust models for studying DNA damage responses and drug-induced stress, enabling researchers to differentiate the functions of TAp73 from other p73 variants in cancer biology.